Want to see DE:DRW8 full AI Analyst Report?
DRW8 Stock Chart & Stats
€55.60
€0.60(1.43%)
At close: 4:00 PM EST
€55.60
€0.60(1.43%)
Day’s Range― - ―
52-Week Range€50.00 - €77.40
Previous CloseN/A
Volume225.00
Average Volume (3M)3.38K
Market Cap
€1.44B
Enterprise Value€1.53B
Total Cash (Recent Filing)€269.09M
Total Debt (Recent Filing)€225.68M
Price to Earnings (P/E)10.2
Beta0.68
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.46%
Share Statistics
EPS (TTM)8.17
Shares Outstanding10,160,000
10 Day Avg. Volume2,278
30 Day Avg. Volume3,385
Financial Highlights & Ratios
PEG Ratio0.74
Price to Book (P/B)0.80
Price to Sales (P/S)0.37
P/FCF Ratio7.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.29
Revenue Forecast (FY)€3.63B
Bulls Say, Bears Say
Bulls Say
Revenue Re-accelerationA large TTM revenue rebound (~73.6%) signals renewed demand and scale across medical and safety segments. Durable top-line recovery strengthens installed base, supports recurring service and consumable sales, and provides a firmer platform for reinvestment and product development over months.
Conservative Balance SheetLow leverage and substantial equity provide financial flexibility to fund capex, R&D, or strategic M&A without stressing liquidity. A de-risked balance sheet reduces default and refinancing risk in cyclical periods and supports multi-month resilience and investment capacity.
Recurring Services & ConsumablesAn installed-base business model with maintenance, repairs and consumables creates predictable, sticky revenue and higher lifetime customer value. Over 2–6 months this supports margin stability, recurring cash generation and customer lock-in, cushioning product sales volatility.
Bears Say
Thin Net MarginsA modest net margin (~4.4%) leaves limited buffer against input-cost inflation, pricing pressure or volume normalization. Structurally thin profitability reduces free cash flow upside and heightens the need for sustained revenue growth to improve returns and fund strategic initiatives.
Volatile Free Cash FlowMaterial swings in free cash flow and negative TTM FCF growth indicate working-capital and reinvestment sensitivity. Persisting volatility can constrain capital allocation, limit predictable dividends or buybacks, and complicate multi-month planning despite accounting profitability.
Moderate Returns On EquityROE around 9% signals only moderate capital efficiency versus high-performing medical-device peers. Sustained shareholder value creation will rely on continued revenue expansion or margin improvement; absent that, returns may remain modest over the medium term.
DRW8 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
Draegerwerk AG & Co. KGaA lowest stock price was €50.00 and its highest was €77.40 in the past 12 months.
What is Draegerwerk AG & Co. KGaA’s market cap?
Draegerwerk AG & Co. KGaA’s market cap is €1.44B.
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
Draegerwerk AG & Co. KGaA’s upcoming earnings report date is Jul 30, 2026 which is in 31 days.
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Draegerwerk AG & Co. KGaA released its earnings results on Apr 30, 2026. The company reported €0.62 earnings per share for the quarter, the consensus estimate of €0.62 by €0.
Is Draegerwerk AG & Co. KGaA overvalued?
According to Wall Street analysts Draegerwerk AG & Co. KGaA’s price is currently Overvalued.
Does Draegerwerk AG & Co. KGaA pay dividends?
Draegerwerk AG & Co. KGaA pays a Annually dividend of €2.21 which represents an annual dividend yield of 3.46%. See more information on Draegerwerk AG & Co. KGaA dividends here
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
Draegerwerk AG & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
Draegerwerk AG & Co. KGaA has 10,160,000 shares outstanding.
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Draegerwerk AG & Co. KGaA reported an EPS of €0.62 in its last earnings report, expectations of €0.62. Following the earnings report the stock price went up 1.157%.
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:DRW8
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Draegerwerk AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
9.79%
Trailing 12-Months
Asset Growth
3.14%
Trailing 12-Months
Company Description
Draegerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and markets comprehensive system solutions, equipment, and support services tailored for acute care environments. This encompasses emergency services, surgical procedures (perioperative care), intensive care units (critical care), and specialized newborn care (perinatal care). Their extensive product portfolio includes items such as anesthesia machines, respiratory ventilators, temperature management devices, monitoring systems for patients, and associated software and consumables. For safety applications, the company delivers essential products, integrated systems, and services designed for personal protection, sophisticated gas detection, and holistic hazard management. These offerings cater to industrial and mining operations, as well as public safety organizations like fire brigades, police forces, and disaster relief agencies. Key safety products range from fixed and portable gas sensing equipment to personal protective gear and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs, comprehensive service packages, and even dedicated fire training facilities for emergency responders.
Technical Analysis
Carl Zeiss Meditec
―
Eckert & Ziegler Strahlen und Medizintechnik
―
MeVis Medical Solutions
―
STRATEC Biomedical
―
Siemens Healthineers AG
―
Options Prices
Currently, No data available
---






